Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.
Saved in:
| Title: | Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study. |
|---|---|
| Authors: | Ciceri F (AUTHOR), Bonini C (AUTHOR), Stanghellini MT (AUTHOR), Bondanza A (AUTHOR), Traversari C (AUTHOR), Salomoni M (AUTHOR), Turchetto L (AUTHOR), Colombi S (AUTHOR), Bernardi M (AUTHOR), Peccatori J (AUTHOR), Pescarollo A (AUTHOR), Servida P (AUTHOR), Magnani Z (AUTHOR), Perna SK (AUTHOR), Valtolina V (AUTHOR), Crippa F (AUTHOR), Callegaro L (AUTHOR), Spoldi E (AUTHOR), Crocchiolo R (AUTHOR), Fleischhauer K (AUTHOR) |
| Source: | Lancet Oncology. May2009, Vol. 10 Issue 5, p489-500. 12p. |
| Database: | Academic Search Ultimate |
| ISSN: | 14702045 |
|---|---|
| DOI: | 10.1016/s1470-2045(09)70074-9 |
